US20120041548A1 - Apparatus for atrioventricular valve repair - Google Patents

Apparatus for atrioventricular valve repair Download PDF

Info

Publication number
US20120041548A1
US20120041548A1 US13/280,112 US201113280112A US2012041548A1 US 20120041548 A1 US20120041548 A1 US 20120041548A1 US 201113280112 A US201113280112 A US 201113280112A US 2012041548 A1 US2012041548 A1 US 2012041548A1
Authority
US
United States
Prior art keywords
fastening mechanism
valve
leaflet
accordance
heart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/280,112
Inventor
Traves Dean Crabtree
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US13/280,112 priority Critical patent/US20120041548A1/en
Publication of US20120041548A1 publication Critical patent/US20120041548A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2454Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses
    • A61F2/2457Chordae tendineae prostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/08Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound
    • A61B17/085Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound with adhesive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00778Operations on blood vessels
    • A61B2017/00783Valvuloplasty
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00867Material properties shape memory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0412Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from suture anchor body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0427Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from the anchor body
    • A61B2017/0437Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from the anchor body the barbs being resilient or spring-like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/044Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors with a threaded shaft, e.g. screws
    • A61B2017/0443Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors with a threaded shaft, e.g. screws the shaft being resilient and having a coiled or helical shape in the released state
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0464Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors for soft tissue

Definitions

  • This invention relates generally to medical methods and apparatus, and more particularly, to methods and apparatus for the endovascular or minimally invasive surgical repair of atrioventricular valves of the heart, including the mitral valve and the tricuspid valve.
  • the heart includes four valves that direct blood through the two sides of the heart.
  • the mitral valve lies between the left atrium and the left ventricle and controls the flow of blood into the left side of the heart.
  • the valve includes two leaflets, an anterior leaflet and a posterior leaflet, that close during systole.
  • the leaflets are passive in that they open and close in response to pressure induced to the leaflets by the pumping of the heart. More specifically, during a normal cycle of heart contraction (systole), the mitral valve functions as a check valve to prevent the flow of oxygenated blood back into the left atrium. In this manner, oxygenated blood is pumped into the aorta through the aortic valve.
  • mitral valve regurgitation in which the mitral valve leaflets become unable to close properly during systole, thus enabling leakage to flow through the mitral valve during systole. Over time, regurgitation of the mitral valve can adversely affect cardiac function and may compromise a patient's quality of life and/or life-span.
  • Mitral valve regurgitation can result from a number of different mechanical defects in the mitral valve.
  • the valve leaflets, the valve chordae which connect the leaflets to the papillary muscles, or the papillary muscles themselves may become damaged or otherwise dysfunctional.
  • the valve annulus may become damaged or weakened and may limit the ability of the mitral valve to close adequately during systole.
  • Percutaneously treatments are less invasive than the treatments mentioned above, but such treatments may be less effective and more difficult to effect repair because of the limited amount of space in and around the mitral valve in which to maneuver a repair device or devices.
  • U.S. Pat. No. 6,875,224 to Grimes describes a percutaneous mitral valve repair method in which the opposed leaflets are each immobilized to enable the two leaflets to be fastened together.
  • U.S. Pat. No. 6,6290,534 to St. Goar et al. describes a plurality of embodiments for use in endovascular repair of cardiac valves in which, in each embodiment, both leaflets are grasped and held firmly in position prior to permanent treatment.
  • grasping both leaflets while the patient's heart is beating may be a time-consuming and laborious task that demands a coordinated effort on the part of the surgical team.
  • to facilitate grasping both leaflets percutaneously may require that the patient's heart be temporarily stopped or slowed by drugs or other techniques. Slowing and/or stopping the patient's heart during surgery may increase the risks to the patient.
  • a method of repairing an atrioventricular valve in a patient comprises accessing the patient's atrioventricular valve percutaneously, securing a fastening mechanism to a valve leaflet, and coupling the valve leaflet, while the patient's heart remains beating, to at least one of a ventricular wall adjacent the atrioventricular valve, a papillary muscle, at least one valve chordae, and a valve annulus to facilitate reducing leakage through the valve.
  • a method of repairing a mitral valve in the heart of a patient comprises accessing the patient's mitral valve percutaneously, securing a first end of a fastening mechanism to a valve leaflet of the mitral valve, and coupling a second end of the fastening mechanism to a cardiac structure other than a mitral valve leaflet to facilitate reducing leakage through the patient's mitral valve during ventricular systole.
  • a method of enhancing operation of a patient's heart valve comprises inserting a guide catheter along the venous system of the patient to approach the mitral valve, guiding a fastening mechanism towards one of a mitral valve and a tricuspid valve within the patient's heart, and securing a first end of the fastening mechanism to one of the mitral valve and the tricuspid valve using one of fusing, gluing, stapling, clipping, riveting, anchoring, and suturing.
  • the method also comprises securing a second end of the fastening mechanism to a cardiac structure other than a valve leaflet to facilitate enhancing operation of the valve during ventricular systole.
  • a medical kit for use in repairing a mitral valve includes a guide catheter and a fastening mechanism.
  • the guide catheter is configured for insertion along the venous system of the patient to approach the mitral valve.
  • the fastening mechanism is positionable percutaneously within the patient using the guide catheter.
  • the fastening mechanism includes a first end and an opposite second end. The first end is configured to couple to the mitral valve using one of fusing, gluing, stapling, clipping, riveting, anchoring, and suturing.
  • the second end is configured to only couple to a cardiac structure other than a valve leaflet to facilitate enhancing operation of the valve during ventricular systole.
  • FIG. 1 is a cross-sectional view of the left and right ventricles of a human heart in diastole;
  • FIG. 2 is an another cross-sectional view of the heart shown in FIG. 1 during systole;
  • FIG. 3 is an exemplary schematic illustration of a fastening mechanism that may be used to facilitate repair of a cardiac valve within the heart shown in FIGS. 1 and 2 ;
  • FIG. 4 is an enlarged view of a portion of the fastening mechanism shown in FIG. 1 and coupled to a papillary muscle in the heart shown in FIGS. 1 and 2 ;
  • FIG. 5 is a schematic view of an alternative embodiment of a portion of a fastening mechanism that may be used to facilitate repair of a cardiac valve within the heart shown in FIGS. 1 and 2 ;
  • FIG. 6 is a schematic view of an another alternative embodiment of a portion of a fastening mechanism that may be used to facilitate repair of a cardiac valve within the heart shown in FIGS. 1 and 2 ;
  • FIG. 7 is a schematic view of a further alternative embodiment of a portion of a fastening mechanism that may be used to facilitate repair of a cardiac valve within the heart shown in FIGS. 1 and 2 ;
  • FIG. 1 is a cross-sectional view of the left and right ventricles 10 and 12 , respectively, of a human heart 14 during diastole. Ventricles 10 and 12 are separated by an interatrial septum 15 .
  • FIG. 2 is a cross-sectional view of heart 14 during systole.
  • the present invention provides methods and apparatus for the endovascular repair of cardiac valves, particularly atrioventricular valves 16 , which inhibit back-flow of blood from a heart ventricle during contraction (systole).
  • the present invention may be used in repairing, but is not limited to repairing, mitral valves 20 .
  • the term “endovascular,” refers to procedure(s) of the present invention that are performed with interventional tools and supporting catheters and other equipment introduced to the heart chambers from the patient's arterial or venous vasculature remote from the heart.
  • the interventional tools and other equipment may be introduced percutaneously, i.e., through an access sheath, or may be introduced via a surgical cut down, and then advanced from the remote access site through the vasculature until they reach heart 14 .
  • the methods and apparatus described herein generally do not require penetrations made directly through an exterior heart muscle, i.e., myocardium, although there may be some instances where penetrations will be made interior to the heart, e.g., through the interatrial septum to provide for a desired access route.
  • the methods and apparatus described herein are not limited to use with percutaneous and intravascular techniques, but rather the present invention may be used with open surgical procedures as well.
  • the atrioventricular valves 16 are each located at a junction of the atria and their respective ventricles.
  • the atrioventricular valve 16 extending between the right atrium 30 and the right ventricle 12 has three valve leaflets (cusps) and is referred to as the tricuspid or right atrioventricular valve 31 .
  • the atrioventricular valve 16 between the left atrium 32 and the left ventricle 10 is a bicuspid valve having only two leaflets or cusps 34 and is generally referred to as the mitral valve 20 .
  • valve leaflets 34 open during diastole when the heart atria fill with blood, allowing the blood to pass into the ventricle.
  • the valve leaflets 34 are pushed together such that the free edges 36 of the leaflets 34 are closed against each other along a line of coaptation to prevent the back-flow of blood into the atria.
  • Back flow of blood or “regurgitation” through the mitral valve 20 is facilitated to be prevented when the leaflets 34 are closed, such that the mitral valve 20 functions as a “check valve” which prevents back-flow when pressure in the left ventricle 10 is higher than that in the left atrium 32 .
  • the mitral valve leaflets 34 are attached to the surrounding heart structure along an annular region referred to as the valve annulus 40 .
  • the free edges 36 of the leaflets 34 are secured to the lower portions of the left ventricle 10 through tendon-like tissue structures, known as chordae tendineae or chordae 42 .
  • the chordae 42 are attached to the papillary muscles 44 which extend upwardly from the lower portions of the left ventricle and interventricular septum 46 .
  • a number of structural defects in the heart can cause mitral valve regurgitation.
  • ruptured chordae 42 may cause a valve leaflet 34 to prolapse if inadequate tension is induced to the leaflet 34 through the remaining unruptured chordae 42 .
  • regurgitation may also occur in patients suffering from cardiomyopathy, wherein the heart 14 is dilated and the increased size prevents the valve leaflet edges 36 from contacting each other properly, or in patients who have suffered ischemic heart disease wherein the functioning of the papillary muscles 44 may be impaired.
  • the free edges 36 of the anterior and posterior leaflets 34 do not contact sufficiently along the line of coaptation, but rather leakage may occur through a gap defined between the leaflets 34 .
  • FIG. 3 is an exemplary schematic illustration of a fastening mechanism 50 that may be used to facilitate repair of an atrioventricular valve 16 within heart 14 (shown in FIGS. 1 and 2 ).
  • FIG. 4 is an enlarged view of a portion of the fastening mechanism shown in FIG. 3 and coupled to a papillary muscle 44 .
  • Fastening mechanism 50 includes a first attachment end 60 and a second attachment end 62 .
  • first attachment end 60 includes a generally deformable clip portion 64 that is sized and shaped to couple to a free edge 36 (shown in FIGS. 1 and 2 ) of a leaflet 34 (shown in FIGS. 1 and 2 ).
  • first attachment end 60 is coupled to leaflet 34 without using clip portion 64 .
  • clip portion 64 is variably selected based on the leaflet 34 being repaired.
  • portion 64 is pinched or crimped against a leaflet free edge 36 to facilitate repair of the valve as described in more detail below.
  • fastening mechanism 50 is coupled to valve 16 such that an outer surface of leaflet free edge 36 is grasped without mechanism 50 penetrating the leaflet tissue.
  • the leaflet free edge 36 is crimped between opposing sides 66 and 68 of portion 64 .
  • portion 64 is coupled to a free edge 36 using any suitable means that enables portion 64 to remain coupled to leaflet free edge 36 , such as, but not limited to, with gluing, stapling, suturing, fusing, riveting, external clips, or any combination thereof
  • first attachment end 60 may be secured to leaflet 34 through atraumatic partial, or full penetration, or piercing of leaflet 34 .
  • first attachment end 60 and/or portion 64 may include attachment prongs that extend from clip portion 64 and that are configured to pinch, partially penetrate, or pierce the leaflet 34 .
  • first attachment end 60 may be inserted from a first side of the leaflet 34 , through leaflet 34 , and outward from an opposite second side of the leaflet 34 . In such an embodiment, in use first attachment end 60 is coupled to, and secured against the second side of the leaflet.
  • first attachment end is inserted only partially through the leaflet 34 , and thus is secured to leaflet tissue intermediate the first and second sides of the leaflet.
  • first attachment end 60 is attached to leaflet 34 using any suitable means that will enable fastening mechanism 50 to function as described herein, such as, but not limited to, an adhesive process, a riveting process, a suturing process, a stapling process, or any combination thereof.
  • a threaded locking member or any other suitable mechanical coupling may be used to secure first attachment end 60 to the leaflet.
  • attachment end 60 may be fused directly to the leaflet 34 using a known fusion process in which laser, RF, microwave or ultrasonic energy, for example, is applied at specified coaptation points.
  • clip portion 64 is fabricated from a formable material that is coated in a protective cloth-like material.
  • Clip portion 64 may be fabricated from any suitable biocompatible material that enables fastening mechanism 50 to function as described herein, such as, but not limited to, titanium alloys, platinum alloys, stainless steel, or any combination thereof.
  • clip portion 64 is coated with a fabric material such as, but not limited to, a DACRON® material, a TEFLON® material, a GORE-TEX®, or any material or combination thereof that enables clip portion 64 to function as described herein.
  • clip portion 64 is covered by a material that encourages tissue in-growth.
  • a tensioning member 70 extends from clip portion 64 to second attachment end 62 .
  • the overall size, shape, and material used in member 70 is variably selected depending on the application.
  • member 70 is fabricated from a mesh material.
  • the relative location of member 70 with respect to clip portion 64 is variably selected based on the amount of tension to be induced, the desired locations for the tension to be induced, and based on the leaflet 34 being repaired.
  • tensioning member 70 includes an attachment pad 74 .
  • fastening mechanism 50 includes more than one tensioning member 70 .
  • fastening mechanism 50 may include a single tensioning member 70 that includes a forked or bifurcated end that includes two pads 74 .
  • fastening tensioning member 70 does not include pad 74 .
  • fastening mechanism 50 includes at least one tensioning member that is formed with a looped end that is sized to circumscribe the cardiac structure to which it is attached, and is cinchable to facilitate securing fastening mechanism 50 to the papillary muscle 44 .
  • Tensioning member 70 facilitates inducing tension to the leaflet 34 being repaired, and pad 74 facilitates distributing loading across the papillary muscle 44 .
  • pad 74 is sized for placement along an external surface of papillary muscle 44 when fastening mechanism 50 is coupled to the papillary muscle 44 .
  • tensioning member 70 and pad 74 are formed integrally together.
  • pad 74 may be securely coupled to member 70 using any of a plurality of known coupling means.
  • member 70 is coupled to papillary muscle 44 using a fastener (not shown) that is inserted at least partially through papillary muscle 44 .
  • the fastener has a tack-like configuration.
  • the fastener is mechanically coupled to the papillary muscle 44 using, for example, a suitable threaded coupling.
  • at least one of a pair of interlocking fasteners is inserted through a pad 74 prior to insertion through the papillary muscle 44 and prior to the two fasteners being interlocked.
  • pad 74 is coupled in position against the papillary muscle 44 by a cinch-type fastener that circumscribes the papillary muscle 44 when securely cinched.
  • pad 74 is coupled directly to the papillary muscle 44 using any suitable means that will enable fastening mechanism 50 to function as described herein, such as, but not limited to, an adhesive process, a riveting process, a suturing process, a coil or corkscrew device, a stapling process, external clips, or any combination thereof.
  • a threaded locking member and a self-locking or spin-lock ratcheting fastener may be used to secure member 70 to the papillary muscle 44 .
  • pad 74 , and/or tensioning member 70 is coupled to the papillary muscle 44 using a flat ribbon that has been heat-set in the shape of double loops.
  • Pad 74 and member 70 may be fabricated from any material that enables pad 74 and member 70 to function as described herein.
  • pad 74 and member 70 may be fabricated from, but are not limited to being fabricated from, a DACRON® material, a TEFLON® material, a GORE-TEX®, or any material or combination.
  • pad 74 and member 70 may be fabricated from, but are not limited to being fabricated from a superelastic material or a shaped memory alloy (SMA) material, such as, but not limited, to Nitinol®, stainless steel, plastic, or any of several known shaped memory alloys (SMA) that have properties that develop a shaped memory effect (SME).
  • SMA shaped memory alloy
  • pad 74 is fabricated from a material that encourages tissue in-growth.
  • first attachment end 60 is coupled securely to mitral valve 20 and second attachment end 62 is coupled to a cardiac structure, such as the papillary muscle 44 .
  • second attachment end 62 may be coupled to any cardiac structure other than a mitral valve leaflet 34 such as, but not limited to, a ventricular wall 46 adjacent the atrioventricular valve 30 , a valve chordae 42 , either intact or ruptured, a valve annulus 36 , an interatrial septum 15 or any combination thereof.
  • second attachment end 62 is coupled to the papillary muscle 44 .
  • member 70 are variably selected to facilitate inducing a desired tension to leaflet 34 and to facilitate improving the ability of the atrioventricular valve 16 to close against the elevated pressures within the ventricle during systole. More specifically, member 70 is variably selected to facilitate modifying operation of the leaflet 34 such that the free ends 36 of the opposed leaflets 34 again contact each other during systole along the line of coaptation to prevent the back-flow or regurgitation of blood through the mitral valve 20 into the atria.
  • FIG. 5 is a schematic view of an alternative embodiment of a portion of a fastening mechanism 100 that may be used to facilitate repair of a cardiac valve 16 (shown in FIGS. 1 and 2 ).
  • Fastening mechanism 100 is substantially similar to fastening mechanism 50 (shown in FIGS. 3 and 4 ) and, components of fastening mechanism 100 that are identical to components of fastening mechanism 50 are identified in FIG. 5 using the same reference numerals used in FIGS. 3 and 4 .
  • fastening mechanism 100 includes first attachment end 60 , second attachment end 62 (shown in FIGS. 3 and 4 ), and at least one tensioning member 110 extending therebetween.
  • tensioning member 110 includes an anchor member 112 . It should be noted that although attachment end 60 is illustrated, the anchor member 112 may also be included at attachment end 62 and/or end 60 , or at any suitable location between ends 60 and 62 depending on the application.
  • Tensioning member 110 is substantially similar to tensioning member 70 and as such, facilitates inducing tension to the leaflet 34 (shown in FIGS. 1 and 2 ) being repaired.
  • tensioning member 110 and anchor member 112 are formed integrally together.
  • anchor member 112 may be securely coupled to tensioning member 110 using any of a plurality of known coupling means.
  • member 110 is coupled to leaflet 34 using anchor member 112 , or any other cardiac structure other than a mitral valve leaflet 34 , such as, but not limited to, a ventricular wall 46 (shown in FIGS. 1 and 2 ) adjacent the atrioventricular valve 30 (shown in FIGS. 1 and 2 ), a valve chordae 42 (shown in FIGS.
  • valve annulus 36 shown in FIGS. 1 and 2
  • interatrial septum 15 shown in FIGS. 1 and 2
  • papillary muscle 44 shown in FIGS. 1 , 2 , and 4
  • anchor member 112 has a distal end 114 that is pointed and is self-piercing that facilitates transmural attachment to a ventricular wall.
  • the anchor member distal end 114 may be fabricated of any material having sufficient rigidity to pierce, and/or at least partially penetrate, through a portion of the cardiac component to which it is intended to be attached.
  • the distal end 114 may be fabricated from, but is not limited to being fabricated from, stainless steel, titanium, various shaped memory or superelastic materials, metal alloys, various polymers, and combinations thereof.
  • the geometries, tip sharpness, and dimensions of anchor member 112 are variably selected to ensure a desired amount of piercing, if any, occurs.
  • the anchor member distal end 114 does not actually pierce the cardiac structure, but rather is positioned in a desired position by a surgical instrument, such as, but not limited to a piercing catheter or a needle.
  • anchor member 112 includes a plurality of anchoring arms 120 that are biased outwardly from tensioning member 110 .
  • anchor member 112 may include, but is not limited to including, a plurality of penetrating and/or non-penetrating petals, wings, propellers, coils, arms, ribbons, tubes, loops, grappling hooks, barbs, or clips, that are extend outwardly from tensioning member 110 to enable fastening mechanism 100 to function as described herein.
  • anchor member 112 may include expandable arms that expand outwardly from a compressed state.
  • the arms 120 function similarly to an umbrella and include a pleated, supported material member that is biased outwardly, as described herein.
  • the cross-sectional shape of arms 120 is illustrated as exemplary only. Rather, anchor member 112 , arms 120 , and tensioning member 110 may be fabricated with any cross-sectional shape that enables fastening mechanism 100 to function as described herein.
  • arms 120 are biased outwardly such as is possible using pre-shaped, resilient metallic rods, for example.
  • the arms 120 may be fabricated from any suitable material and in any suitable manner that enables arms 120 to function as described herein.
  • arms 120 may be fabricated from, but are not limited to being fabricated from Nitinol®, stainless steel, plastic, superelastic alloys, polymers, or any of several known shaped memory alloys (SMA) that have properties that develop a shaped memory effect (SME).
  • arms 120 may be fabricated from, but are not limited to being fabricated from, a DACRON® material, a TEFLON® material, a GORE-TEX®, or any material or combination.
  • arms 120 are fabricated from a material that encourages tissue in-growth.
  • arms 120 are advanced through the penetration or opening and are displaced outwardly. More specifically, as tensioning member 100 is withdrawn or retracted from the opening in an opposite direction to that of insertion within the opening, because arms 120 are biased outwardly from tensioning member 100 . More specifically, the biasing of the arms 120 causes the arms 120 to contact the surface of the cardiac component radially outward from the opening, such that the arms 120 are not retractable through the opening as tensioning member 100 is withdrawn from the opening. Rather, as tensioning member 100 is withdrawn from the opening, anchor member 112 is secured against a tissue surface of the cardiac component.
  • FIG. 6 is a schematic view of an alternative embodiment of a portion of a fastening mechanism 150 that may be used to facilitate repair of a cardiac valve 16 (shown in FIGS. 1 and 2 ).
  • Fastening mechanism 150 is substantially similar to fastening mechanisms 50 and 100 (shown in FIGS. 3 and 4 , and 5 , respectively) and, components of fastening mechanism 150 that are identical to components of fastening mechanism 50 and 100 are identified in FIG. 6 using the same reference numerals used in FIGS. 3-5 . Accordingly, fastening mechanism 150 includes first attachment end 60 (shown in FIGS. 3-5 ), second attachment end 62 (shown in FIGS. 3 and 4 ), and at least one tensioning member 152 extending therebetween.
  • tensioning member 152 includes an anchor member 156 . It should be noted that although attachment end 62 is illustrated, the anchor member 156 may also be included at attachment end 60 and/or end 62 , or at any suitable location between ends 60 and 62 depending on the application.
  • Tensioning member 152 is substantially similar to tensioning member 70 , and/or tensioning member 110 , and as such, facilitates inducing tension to the leaflet 34 (shown in FIGS. 1 and 2 ) being repaired.
  • tensioning member 152 and anchor member 156 are formed integrally together.
  • anchor member 156 may be securely coupled to tensioning member 152 using any of a plurality of known coupling means.
  • member 152 is coupled to leaflet 34 using anchor member 156 , or any other cardiac structure other than a mitral valve leaflet 34 , such as, but not limited to, a ventricular wall 46 (shown in FIGS. 1 and 2 ) adjacent the atrioventricular valve 30 (shown in FIGS.
  • valve chordae 42 shown in FIGS. 1 and 2
  • valve annulus 36 shown in FIGS. 1 and 2
  • interatrial septum 15 shown in FIGS. 1 and 2
  • papillary muscle 44 shown in FIGS. 1 , 2 , and 4
  • anchor member 156 is formed with a cork-screw or coil configuration and has a distal end 160 that is pointed and is self-piercing. Accordingly, the anchor member 156 may be fabricated of any material having sufficient rigidity to pierce, and/or at least partially penetrate, through a portion of the cardiac component to which it is intended to be attached.
  • the distal end 156 may be fabricated from, but is not limited to being fabricated from, stainless steel, titanium, various shape memory or superelastic materials, metal alloys, various polymers, and combinations thereof.
  • the anchor member 156 is not self-tapping, but rather is threadably coupled within a starter hole formed a surgical instrument, such as, but not limited to a piercing catheter or a needle.
  • anchor member 156 may be formed from a shape memory wire that is annealed or heat-set in a straight configuration and then coiled. In such an embodiment, anchor member 156 may be processed to have different properties by varying the diameter and tension therein along its length. For example, when anchor member 156 is heated to a pre-determined temperature, such as with RF energy, a designated portion of anchor member 156 will become a randomly oriented mass of material having self-locking struts to prevent disentanglement. When the anchor member 156 is heated to a different pre-determined temperature, a full entanglement of occurs such that anchor member 156 is compressed together.
  • a pre-determined temperature such as with RF energy
  • anchor member 156 includes a plurality of tines or arms that are biased outwardly from member 156 , and more particularly from tip 160 .
  • the arms facilitate securing the anchor member 156 in position within the cardiac structure to which it is embedded.
  • anchor member 156 may include expandable arms that expand outwardly from a compressed state.
  • anchor member 156 may include other self-locking struts that facilitate preventing member 156 from backing out of the cardiac structure to which it is threadalby coupled.
  • the cross-sectional shape of anchor member 156 is illustrated as exemplary only.
  • anchor member 156 and tensioning member 152 may be fabricated with any cross-sectional shape, dimensions, or material that enables fastening mechanism 150 to function as described herein.
  • anchor member 156 may be formed with, but is not limited to being formed with, a self-tapping screw configuration, a mesh configuration, or with a helical configuration.
  • anchor member 156 is formed with a coiled configuration having a helical filament that includes a secondary helical structure that includes, for example, a plurality of loops.
  • anchor member 156 may include an inner element fabricated from a shaped memory material and an outer element that is substantially concentrically aligned with respect to the inner element, and is fabricated from a second material, such as a radiopaque material or a heat-activated material.
  • the coil may be fabricated with a stacked coil configuration in which no space is defined between adjacent windings of the coil, but rather, the coil assumes a coil configuration when heated to a pre-determined temperature as it is deployed.
  • FIG. 7 is a schematic view of an alternative embodiment of a portion of a tensioning member 200 that may be used to facilitate repair of a cardiac valve 16 (shown in FIGS. 1 and 2 ).
  • Tensioning member 200 extends between first and second attachment ends 60 and 62 (shown in FIGS. 3 and 4 ) and in the exemplary embodiment, includes at least two anchoring loops 202 and 204 , and an adjustment mechanism 206 extending between loops 202 and 204 .
  • loops 202 and 204 are each formed integrally with respective attachment ends 60 and 62 .
  • loops 202 and 204 are coupled to ends 60 and 62 using any suitable coupling means.
  • adjustment mechanism 206 enables each attachment end 60 and 62 to be coupled to a leaflet 34 (shown in FIGS. 1 and 2 ) and to any other cardiac structure other than a mitral valve leaflet 34 , without tension being induced to either end 60 or 62 . Moreover, once ends 60 and 62 are coupled to the leaflet 34 and the cardiac structure, adjustment mechanism 206 enables a pre-determined tension to be induced between the leaflet 34 and the cardiac structure.
  • adjustment mechanism 206 functions similarly to a drawstring and includes a locking mechanism 220 that facilitates maintaining a desired tension between the leaflet 34 and the cardiac structure. More specifically, after ends 60 and 62 have each been securely coupled to the leaflet and the cardiac structure, as adjustment loop 222 is pulled away from ends 60 and 62 , adjustment mechanism 206 is drawn radially inward between ends 60 and 62 , inducing tension between the leaflet 34 and the cardiac structure, and locking mechanism 220 is coupled to adjustment loop 222 to facilitate ensuring that ends 60 and 62 are maintained in their relative position such that the tension induced between ends 60 and 62 is maintained.
  • adjustment mechanism 206 does not include locking mechanism 222 , but rather any suitable method of maintaining the tension between ends 60 and 62 may be utilized, such as, but not limited to, self-locking twist fastener devices or swivel fasteners. Moreover, in a further embodiment, adjustment mechanism 206 does not include locking mechanism 220 , but rather the tension induced by the placement of loop 222 is maintained by a knot tied in position adjacent loop 222 .
  • adjustment mechanisms other than mechanism 206 may be used, such as, but not limited to, the installation of a spreader bar mechanism within at least one loop of a daisy chained tension member, the use of a turnbuckle-type mechanism, and/or the use of tensioning member that is shortened as it is twisted, such as would be possible with a tourniquet-type attachment.
  • at least a portion of adjustment mechanism 206 is fabricated from a shaped metal alloy that is formed into a component that when coupled within a fastener assembly either constricts or bows outwardly to induce tension between the ends 60 and 62 .
  • FIG. 8 is a flowchart illustrating an exemplary method for the endovascular repair of a cardiac valve.
  • the mitral valve, or other atrioventricular valve being repaired is accessed percutaneously 300 .
  • the approach to the mitral valve may be “antegrade” and require entry into the left atrium by crossing the interatrial septum.
  • approach to the mitral valve can be “retrograde” wherein the left ventricle is entered through the aortic valve.
  • the interventional tools and supporting catheter(s) will be positioned 302 endovascularly adjacent the valve being repaired.
  • the present invention may be used with open surgical techniques wherein the heart is stopped and the heart valve accessed through the myocardial tissue.
  • the interventional tools used for performing the valve repairs may be specifically designed for use with the present invention, or existing tools may be modified to accommodate the present invention.
  • a 1° catheter is used to position or guide a plurality of smaller catheters in which the 1° catheter is used to accomplish general positioning of the device relative to the valve being repaired, and the smaller catheters facilitate the more precise positioning necessary to repair the valve in accordance with the present invention.
  • a guide catheter, a needle bearing catheter, an introducer, or a similar device may be used.
  • the leaflet to be repaired is captured 310 and the first attachment end of the fastening mechanism is securely coupled to the leaflet 312 .
  • the fastening mechanism may be coupled to the leaflet in a plurality of manners, but in each case, the first attachment end of the mechanism is securely coupled to the valve leaflet in need of repair.
  • the leaflet may be captured 310 using any of a plurality of known methods, including, but not limited to using grasping pins, articulated graspers, vacuum-assisted graspers, or any other suitable method.
  • the second attachment end of the fastening mechanism is then securely coupled 330 to a cardiac structure other than a mitral valve leaflet.
  • the tension induced 332 to the mitral valve leaflet is selected to substantially simulate the same tension, operation, and functionality of a natural chordae member coupled to the leaflet.
  • tension induced to the mitral valve leaflet is adjustable via adjustments of the tensioning member.
  • TEE trans-esophegeal echocardiography
  • ICE intracardiac echocardiography
  • MRI catheter based magnetic resonance imaging
  • CT computed tomography

Abstract

Apparatus for use in repairing an atrioventricular valve in a patient is provided. The apparatus comprises a fastening mechanism for use in repairing a mitral valve in the heart of a patient. The mechanism includes a first end, a second end, and a body extending therebetween. The mechanism is configured to be positioned in the patient's heart using at least one of a guide catheter and an interventional tool that positions the fastening mechanism without penetrating a myocardium. The first end is configured to couple to the valve leaflet while the heart is non-arrested. The second end is configured to couple to a structure other than the valve leaflet, such that the mechanism remains coupled within the heart after being coupled within the heart and simulates the function of a natural chordae.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. patent application Ser. No. 11/287,011, filed Nov. 23, 2005. The parent patent application is incorporated herein by reference in its entirety.
  • BACKGROUND OF THE INVENTION
  • This invention relates generally to medical methods and apparatus, and more particularly, to methods and apparatus for the endovascular or minimally invasive surgical repair of atrioventricular valves of the heart, including the mitral valve and the tricuspid valve.
  • The heart includes four valves that direct blood through the two sides of the heart. The mitral valve lies between the left atrium and the left ventricle and controls the flow of blood into the left side of the heart. The valve includes two leaflets, an anterior leaflet and a posterior leaflet, that close during systole. The leaflets are passive in that they open and close in response to pressure induced to the leaflets by the pumping of the heart. More specifically, during a normal cycle of heart contraction (systole), the mitral valve functions as a check valve to prevent the flow of oxygenated blood back into the left atrium. In this manner, oxygenated blood is pumped into the aorta through the aortic valve.
  • Occasionally, the mitral valve is formed abnormally through a congenital condition. More often, however, the mitral valve degenerates with age. Among the problems that can develop is mitral valve regurgitation in which the mitral valve leaflets become unable to close properly during systole, thus enabling leakage to flow through the mitral valve during systole. Over time, regurgitation of the mitral valve can adversely affect cardiac function and may compromise a patient's quality of life and/or life-span.
  • Mitral valve regurgitation can result from a number of different mechanical defects in the mitral valve. For example, the valve leaflets, the valve chordae which connect the leaflets to the papillary muscles, or the papillary muscles themselves may become damaged or otherwise dysfunctional. Moreover, the valve annulus may become damaged or weakened and may limit the ability of the mitral valve to close adequately during systole.
  • Known treatments for mitral valve regurgitation commonly rely on valve replacement or annuloplasty, or strengthening of the mitral valve through surgical repairs and/or implanting a mechanical structure within the mitral valve. For example, the most prevalent and widely accepted known techniques to correct mitral valve regurgitation, repair the mitral valve via open heart surgery. During such an invasive surgical procedure, it is known to suture adjacent segments of the opposed valve leaflets together in a procedure known as a “bow-tie” or “edge-to-edge” surgical technique. Although each of the afore-mentioned treatments can be effective, generally known treatments rely on open heart surgery wherein the patient's chest is opened and the patient's heart is stopped while the patient is place on a cardiopulmonary bypass. The need to open the patient's chest and to place the patient on a cardiopulmonary bypass creates inherent risks that may be traumatic to the patient.
  • Percutaneously treatments are less invasive than the treatments mentioned above, but such treatments may be less effective and more difficult to effect repair because of the limited amount of space in and around the mitral valve in which to maneuver a repair device or devices. For example, U.S. Pat. No. 6,875,224 to Grimes describes a percutaneous mitral valve repair method in which the opposed leaflets are each immobilized to enable the two leaflets to be fastened together. Furthermore, U.S. Pat. No. 6,6290,534 to St. Goar et al. describes a plurality of embodiments for use in endovascular repair of cardiac valves in which, in each embodiment, both leaflets are grasped and held firmly in position prior to permanent treatment. However, grasping both leaflets while the patient's heart is beating may be a time-consuming and laborious task that demands a coordinated effort on the part of the surgical team. Moreover, to facilitate grasping both leaflets percutaneously may require that the patient's heart be temporarily stopped or slowed by drugs or other techniques. Slowing and/or stopping the patient's heart during surgery may increase the risks to the patient.
  • BRIEF DESCRIPTION OF THE INVENTION
  • In one aspect, a method of repairing an atrioventricular valve in a patient is provided. The method comprises accessing the patient's atrioventricular valve percutaneously, securing a fastening mechanism to a valve leaflet, and coupling the valve leaflet, while the patient's heart remains beating, to at least one of a ventricular wall adjacent the atrioventricular valve, a papillary muscle, at least one valve chordae, and a valve annulus to facilitate reducing leakage through the valve.
  • In another aspect, a method of repairing a mitral valve in the heart of a patient is provided. The method comprises accessing the patient's mitral valve percutaneously, securing a first end of a fastening mechanism to a valve leaflet of the mitral valve, and coupling a second end of the fastening mechanism to a cardiac structure other than a mitral valve leaflet to facilitate reducing leakage through the patient's mitral valve during ventricular systole.
  • In a further aspect, a method of enhancing operation of a patient's heart valve is provided. The method comprises inserting a guide catheter along the venous system of the patient to approach the mitral valve, guiding a fastening mechanism towards one of a mitral valve and a tricuspid valve within the patient's heart, and securing a first end of the fastening mechanism to one of the mitral valve and the tricuspid valve using one of fusing, gluing, stapling, clipping, riveting, anchoring, and suturing. The method also comprises securing a second end of the fastening mechanism to a cardiac structure other than a valve leaflet to facilitate enhancing operation of the valve during ventricular systole.
  • In an additional aspect, a medical kit for use in repairing a mitral valve is provided. The kit includes a guide catheter and a fastening mechanism. The guide catheter is configured for insertion along the venous system of the patient to approach the mitral valve. The fastening mechanism is positionable percutaneously within the patient using the guide catheter. The fastening mechanism includes a first end and an opposite second end. The first end is configured to couple to the mitral valve using one of fusing, gluing, stapling, clipping, riveting, anchoring, and suturing. The second end is configured to only couple to a cardiac structure other than a valve leaflet to facilitate enhancing operation of the valve during ventricular systole.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a cross-sectional view of the left and right ventricles of a human heart in diastole;
  • FIG. 2 is an another cross-sectional view of the heart shown in FIG. 1 during systole;
  • FIG. 3 is an exemplary schematic illustration of a fastening mechanism that may be used to facilitate repair of a cardiac valve within the heart shown in FIGS. 1 and 2;
  • FIG. 4 is an enlarged view of a portion of the fastening mechanism shown in FIG. 1 and coupled to a papillary muscle in the heart shown in FIGS. 1 and 2;
  • FIG. 5 is a schematic view of an alternative embodiment of a portion of a fastening mechanism that may be used to facilitate repair of a cardiac valve within the heart shown in FIGS. 1 and 2;
  • FIG. 6 is a schematic view of an another alternative embodiment of a portion of a fastening mechanism that may be used to facilitate repair of a cardiac valve within the heart shown in FIGS. 1 and 2;
  • FIG. 7 is a schematic view of a further alternative embodiment of a portion of a fastening mechanism that may be used to facilitate repair of a cardiac valve within the heart shown in FIGS. 1 and 2; and
  • FIG. 8 is a flowchart illustrating an exemplary method for the endovascular repair of a cardiac valve.
  • DETAILED DESCRIPTION OF THE INVENTION
  • FIG. 1 is a cross-sectional view of the left and right ventricles 10 and 12, respectively, of a human heart 14 during diastole. Ventricles 10 and 12 are separated by an interatrial septum 15. FIG. 2 is a cross-sectional view of heart 14 during systole. The present invention provides methods and apparatus for the endovascular repair of cardiac valves, particularly atrioventricular valves 16, which inhibit back-flow of blood from a heart ventricle during contraction (systole). In particular, the present invention may be used in repairing, but is not limited to repairing, mitral valves 20.
  • As used herein, the term “endovascular,” refers to procedure(s) of the present invention that are performed with interventional tools and supporting catheters and other equipment introduced to the heart chambers from the patient's arterial or venous vasculature remote from the heart. The interventional tools and other equipment may be introduced percutaneously, i.e., through an access sheath, or may be introduced via a surgical cut down, and then advanced from the remote access site through the vasculature until they reach heart 14. As such, the methods and apparatus described herein generally do not require penetrations made directly through an exterior heart muscle, i.e., myocardium, although there may be some instances where penetrations will be made interior to the heart, e.g., through the interatrial septum to provide for a desired access route. Moreover, as will be appreciated by one of ordinary skill in the art, the methods and apparatus described herein are not limited to use with percutaneous and intravascular techniques, but rather the present invention may be used with open surgical procedures as well.
  • The atrioventricular valves 16 are each located at a junction of the atria and their respective ventricles. The atrioventricular valve 16 extending between the right atrium 30 and the right ventricle 12 has three valve leaflets (cusps) and is referred to as the tricuspid or right atrioventricular valve 31. The atrioventricular valve 16 between the left atrium 32 and the left ventricle 10 is a bicuspid valve having only two leaflets or cusps 34 and is generally referred to as the mitral valve 20.
  • During operation of the heart 14, the valve leaflets 34 open during diastole when the heart atria fill with blood, allowing the blood to pass into the ventricle. During systole, however, the valve leaflets 34 are pushed together such that the free edges 36 of the leaflets 34 are closed against each other along a line of coaptation to prevent the back-flow of blood into the atria. Back flow of blood or “regurgitation” through the mitral valve 20 is facilitated to be prevented when the leaflets 34 are closed, such that the mitral valve 20 functions as a “check valve” which prevents back-flow when pressure in the left ventricle 10 is higher than that in the left atrium 32.
  • The mitral valve leaflets 34 are attached to the surrounding heart structure along an annular region referred to as the valve annulus 40. The free edges 36 of the leaflets 34 are secured to the lower portions of the left ventricle 10 through tendon-like tissue structures, known as chordae tendineae or chordae 42. The chordae 42 are attached to the papillary muscles 44 which extend upwardly from the lower portions of the left ventricle and interventricular septum 46.
  • A number of structural defects in the heart can cause mitral valve regurgitation. For example, ruptured chordae 42 may cause a valve leaflet 34 to prolapse if inadequate tension is induced to the leaflet 34 through the remaining unruptured chordae 42. Moreover, and for example, regurgitation may also occur in patients suffering from cardiomyopathy, wherein the heart 14 is dilated and the increased size prevents the valve leaflet edges 36 from contacting each other properly, or in patients who have suffered ischemic heart disease wherein the functioning of the papillary muscles 44 may be impaired. Generally during regurgitation the free edges 36 of the anterior and posterior leaflets 34 do not contact sufficiently along the line of coaptation, but rather leakage may occur through a gap defined between the leaflets 34.
  • FIG. 3 is an exemplary schematic illustration of a fastening mechanism 50 that may be used to facilitate repair of an atrioventricular valve 16 within heart 14 (shown in FIGS. 1 and 2). FIG. 4 is an enlarged view of a portion of the fastening mechanism shown in FIG. 3 and coupled to a papillary muscle 44. Fastening mechanism 50 includes a first attachment end 60 and a second attachment end 62. In the exemplary embodiment, first attachment end 60 includes a generally deformable clip portion 64 that is sized and shaped to couple to a free edge 36 (shown in FIGS. 1 and 2) of a leaflet 34 (shown in FIGS. 1 and 2). In alternative embodiments, first attachment end 60 is coupled to leaflet 34 without using clip portion 64.
  • Overall dimensions of, and material properties used in fabricating, clip portion 64 are variably selected based on the leaflet 34 being repaired. In the exemplary embodiment, portion 64 is pinched or crimped against a leaflet free edge 36 to facilitate repair of the valve as described in more detail below. More specifically, in this embodiment, fastening mechanism 50 is coupled to valve 16 such that an outer surface of leaflet free edge 36 is grasped without mechanism 50 penetrating the leaflet tissue. Specifically, in the exemplary embodiment, the leaflet free edge 36 is crimped between opposing sides 66 and 68 of portion 64. In another embodiment, portion 64 is coupled to a free edge 36 using any suitable means that enables portion 64 to remain coupled to leaflet free edge 36, such as, but not limited to, with gluing, stapling, suturing, fusing, riveting, external clips, or any combination thereof
  • Alternatively, first attachment end 60 may be secured to leaflet 34 through atraumatic partial, or full penetration, or piercing of leaflet 34. For example, first attachment end 60 and/or portion 64 may include attachment prongs that extend from clip portion 64 and that are configured to pinch, partially penetrate, or pierce the leaflet 34. In one alternative embodiment, first attachment end 60 may be inserted from a first side of the leaflet 34, through leaflet 34, and outward from an opposite second side of the leaflet 34. In such an embodiment, in use first attachment end 60 is coupled to, and secured against the second side of the leaflet. In another alternative embodiment, first attachment end is inserted only partially through the leaflet 34, and thus is secured to leaflet tissue intermediate the first and second sides of the leaflet.
  • In another alternative embodiment, first attachment end 60 is attached to leaflet 34 using any suitable means that will enable fastening mechanism 50 to function as described herein, such as, but not limited to, an adhesive process, a riveting process, a suturing process, a stapling process, or any combination thereof. In a further alternative embodiment, a threaded locking member or any other suitable mechanical coupling, may be used to secure first attachment end 60 to the leaflet. In another alternative embodiment, attachment end 60 may be fused directly to the leaflet 34 using a known fusion process in which laser, RF, microwave or ultrasonic energy, for example, is applied at specified coaptation points.
  • In the exemplary embodiment, clip portion 64 is fabricated from a formable material that is coated in a protective cloth-like material. Clip portion 64 may be fabricated from any suitable biocompatible material that enables fastening mechanism 50 to function as described herein, such as, but not limited to, titanium alloys, platinum alloys, stainless steel, or any combination thereof. In the exemplary embodiment, clip portion 64 is coated with a fabric material such as, but not limited to, a DACRON® material, a TEFLON® material, a GORE-TEX®, or any material or combination thereof that enables clip portion 64 to function as described herein. In one embodiment, clip portion 64 is covered by a material that encourages tissue in-growth.
  • In the exemplary embodiment, a tensioning member 70 extends from clip portion 64 to second attachment end 62. The overall size, shape, and material used in member 70 is variably selected depending on the application. For example, in one embodiment, member 70 is fabricated from a mesh material. The relative location of member 70 with respect to clip portion 64 is variably selected based on the amount of tension to be induced, the desired locations for the tension to be induced, and based on the leaflet 34 being repaired.
  • In the exemplary embodiment, tensioning member 70 includes an attachment pad 74. The overall size, shape, thickness, and material used in fabricating pad 74, as well as the number and location of pad 74, are variably selected based on the intended use of fastening mechanism 50. Alternatively, fastening mechanism 50 includes more than one tensioning member 70. In another alternative embodiment, fastening mechanism 50 may include a single tensioning member 70 that includes a forked or bifurcated end that includes two pads 74. In yet another alternative embodiment, fastening tensioning member 70 does not include pad 74. In a further alternative embodiment, fastening mechanism 50 includes at least one tensioning member that is formed with a looped end that is sized to circumscribe the cardiac structure to which it is attached, and is cinchable to facilitate securing fastening mechanism 50 to the papillary muscle 44. Tensioning member 70 facilitates inducing tension to the leaflet 34 being repaired, and pad 74 facilitates distributing loading across the papillary muscle 44. Moreover, pad 74 is sized for placement along an external surface of papillary muscle 44 when fastening mechanism 50 is coupled to the papillary muscle 44.
  • In the exemplary embodiment, tensioning member 70 and pad 74 are formed integrally together. Alternatively, pad 74 may be securely coupled to member 70 using any of a plurality of known coupling means. In the exemplary embodiment, member 70 is coupled to papillary muscle 44 using a fastener (not shown) that is inserted at least partially through papillary muscle 44. In one embodiment, the fastener has a tack-like configuration. In another embodiment, the fastener is mechanically coupled to the papillary muscle 44 using, for example, a suitable threaded coupling. In a further embodiment, at least one of a pair of interlocking fasteners is inserted through a pad 74 prior to insertion through the papillary muscle 44 and prior to the two fasteners being interlocked. In another embodiment, pad 74 is coupled in position against the papillary muscle 44 by a cinch-type fastener that circumscribes the papillary muscle 44 when securely cinched. In another alternative embodiment, pad 74 is coupled directly to the papillary muscle 44 using any suitable means that will enable fastening mechanism 50 to function as described herein, such as, but not limited to, an adhesive process, a riveting process, a suturing process, a coil or corkscrew device, a stapling process, external clips, or any combination thereof. In a further alternative embodiment, a threaded locking member and a self-locking or spin-lock ratcheting fastener may be used to secure member 70 to the papillary muscle 44. In yet a further alternative embodiment, pad 74, and/or tensioning member 70 is coupled to the papillary muscle 44 using a flat ribbon that has been heat-set in the shape of double loops.
  • Pad 74 and member 70 may be fabricated from any material that enables pad 74 and member 70 to function as described herein. For example, pad 74 and member 70 may be fabricated from, but are not limited to being fabricated from, a DACRON® material, a TEFLON® material, a GORE-TEX®, or any material or combination. In addition, depending on the application, pad 74 and member 70 may be fabricated from, but are not limited to being fabricated from a superelastic material or a shaped memory alloy (SMA) material, such as, but not limited, to Nitinol®, stainless steel, plastic, or any of several known shaped memory alloys (SMA) that have properties that develop a shaped memory effect (SME). In one embodiment, pad 74 is fabricated from a material that encourages tissue in-growth.
  • During use, to repair a mitral valve 20 using fastening mechanism 50, first attachment end 60 is coupled securely to mitral valve 20 and second attachment end 62 is coupled to a cardiac structure, such as the papillary muscle 44. Alternatively, second attachment end 62 may be coupled to any cardiac structure other than a mitral valve leaflet 34 such as, but not limited to, a ventricular wall 46 adjacent the atrioventricular valve 30, a valve chordae 42, either intact or ruptured, a valve annulus 36, an interatrial septum 15 or any combination thereof. In the exemplary embodiment, second attachment end 62 is coupled to the papillary muscle 44. More specifically, when end 62 is firmly secured to the papillary muscle 44, pad 74 is retained tightly against the exterior surface of the papillary muscle 44. As such, loading induced to the papillary muscle from fastening mechanism 50 is distributed across pad 74.
  • In the exemplary embodiment, overall dimensions and material properties of member 70 are variably selected to facilitate inducing a desired tension to leaflet 34 and to facilitate improving the ability of the atrioventricular valve 16 to close against the elevated pressures within the ventricle during systole. More specifically, member 70 is variably selected to facilitate modifying operation of the leaflet 34 such that the free ends 36 of the opposed leaflets 34 again contact each other during systole along the line of coaptation to prevent the back-flow or regurgitation of blood through the mitral valve 20 into the atria.
  • FIG. 5 is a schematic view of an alternative embodiment of a portion of a fastening mechanism 100 that may be used to facilitate repair of a cardiac valve 16 (shown in FIGS. 1 and 2). Fastening mechanism 100 is substantially similar to fastening mechanism 50 (shown in FIGS. 3 and 4) and, components of fastening mechanism 100 that are identical to components of fastening mechanism 50 are identified in FIG. 5 using the same reference numerals used in FIGS. 3 and 4. Accordingly, fastening mechanism 100 includes first attachment end 60, second attachment end 62 (shown in FIGS. 3 and 4), and at least one tensioning member 110 extending therebetween. In the exemplary embodiment, tensioning member 110 includes an anchor member 112. It should be noted that although attachment end 60 is illustrated, the anchor member 112 may also be included at attachment end 62 and/or end 60, or at any suitable location between ends 60 and 62 depending on the application.
  • Tensioning member 110 is substantially similar to tensioning member 70 and as such, facilitates inducing tension to the leaflet 34 (shown in FIGS. 1 and 2) being repaired. In the exemplary embodiment, tensioning member 110 and anchor member 112 are formed integrally together. Alternatively, anchor member 112 may be securely coupled to tensioning member 110 using any of a plurality of known coupling means. In the exemplary embodiment, member 110 is coupled to leaflet 34 using anchor member 112, or any other cardiac structure other than a mitral valve leaflet 34, such as, but not limited to, a ventricular wall 46 (shown in FIGS. 1 and 2) adjacent the atrioventricular valve 30 (shown in FIGS. 1 and 2), a valve chordae 42 (shown in FIGS. 1 and 2), either intact or ruptured, a valve annulus 36 (shown in FIGS. 1 and 2), an interatrial septum 15 (shown in FIGS. 1 and 2), a papillary muscle 44 (shown in FIGS. 1, 2, and 4), or any combination thereof
  • In the exemplary embodiment, anchor member 112 has a distal end 114 that is pointed and is self-piercing that facilitates transmural attachment to a ventricular wall. Accordingly, the anchor member distal end 114 may be fabricated of any material having sufficient rigidity to pierce, and/or at least partially penetrate, through a portion of the cardiac component to which it is intended to be attached. For example, the distal end 114 may be fabricated from, but is not limited to being fabricated from, stainless steel, titanium, various shaped memory or superelastic materials, metal alloys, various polymers, and combinations thereof. Moreover, the geometries, tip sharpness, and dimensions of anchor member 112 are variably selected to ensure a desired amount of piercing, if any, occurs. In an alternative embodiment, the anchor member distal end 114 does not actually pierce the cardiac structure, but rather is positioned in a desired position by a surgical instrument, such as, but not limited to a piercing catheter or a needle.
  • In the exemplary embodiment, anchor member 112 includes a plurality of anchoring arms 120 that are biased outwardly from tensioning member 110. Alternatively, anchor member 112 may include, but is not limited to including, a plurality of penetrating and/or non-penetrating petals, wings, propellers, coils, arms, ribbons, tubes, loops, grappling hooks, barbs, or clips, that are extend outwardly from tensioning member 110 to enable fastening mechanism 100 to function as described herein. Moreover, in other embodiments, anchor member 112 may include expandable arms that expand outwardly from a compressed state. For example, in one embodiment, the arms 120 function similarly to an umbrella and include a pleated, supported material member that is biased outwardly, as described herein. Furthermore, the cross-sectional shape of arms 120 is illustrated as exemplary only. Rather, anchor member 112, arms 120, and tensioning member 110 may be fabricated with any cross-sectional shape that enables fastening mechanism 100 to function as described herein.
  • In the exemplary embodiment, arms 120 are biased outwardly such as is possible using pre-shaped, resilient metallic rods, for example. Alternatively, the arms 120 may be fabricated from any suitable material and in any suitable manner that enables arms 120 to function as described herein. For example, arms 120 may be fabricated from, but are not limited to being fabricated from Nitinol®, stainless steel, plastic, superelastic alloys, polymers, or any of several known shaped memory alloys (SMA) that have properties that develop a shaped memory effect (SME). Moreover, arms 120 may be fabricated from, but are not limited to being fabricated from, a DACRON® material, a TEFLON® material, a GORE-TEX®, or any material or combination. In one embodiment, arms 120 are fabricated from a material that encourages tissue in-growth.
  • During installation, after distal end 114 has penetrated at least partially through the cardiac component to which it is being attached, arms 120 are advanced through the penetration or opening and are displaced outwardly. More specifically, as tensioning member 100 is withdrawn or retracted from the opening in an opposite direction to that of insertion within the opening, because arms 120 are biased outwardly from tensioning member 100. More specifically, the biasing of the arms 120 causes the arms 120 to contact the surface of the cardiac component radially outward from the opening, such that the arms 120 are not retractable through the opening as tensioning member 100 is withdrawn from the opening. Rather, as tensioning member 100 is withdrawn from the opening, anchor member 112 is secured against a tissue surface of the cardiac component.
  • FIG. 6 is a schematic view of an alternative embodiment of a portion of a fastening mechanism 150 that may be used to facilitate repair of a cardiac valve 16 (shown in FIGS. 1 and 2). Fastening mechanism 150 is substantially similar to fastening mechanisms 50 and 100 (shown in FIGS. 3 and 4, and 5, respectively) and, components of fastening mechanism 150 that are identical to components of fastening mechanism 50 and 100 are identified in FIG. 6 using the same reference numerals used in FIGS. 3-5. Accordingly, fastening mechanism 150 includes first attachment end 60 (shown in FIGS. 3-5), second attachment end 62 (shown in FIGS. 3 and 4), and at least one tensioning member 152 extending therebetween. In the exemplary embodiment, tensioning member 152 includes an anchor member 156. It should be noted that although attachment end 62 is illustrated, the anchor member 156 may also be included at attachment end 60 and/or end 62, or at any suitable location between ends 60 and 62 depending on the application.
  • Tensioning member 152 is substantially similar to tensioning member 70, and/or tensioning member 110, and as such, facilitates inducing tension to the leaflet 34 (shown in FIGS. 1 and 2) being repaired. In the exemplary embodiment, tensioning member 152 and anchor member 156 are formed integrally together. Alternatively, anchor member 156 may be securely coupled to tensioning member 152 using any of a plurality of known coupling means. In the exemplary embodiment, member 152 is coupled to leaflet 34 using anchor member 156, or any other cardiac structure other than a mitral valve leaflet 34, such as, but not limited to, a ventricular wall 46 (shown in FIGS. 1 and 2) adjacent the atrioventricular valve 30 (shown in FIGS. 1 and 2), a valve chordae 42 (shown in FIGS. 1 and 2), either intact or ruptured, a valve annulus 36 (shown in FIGS. 1 and 2), an interatrial septum 15 (shown in FIGS. 1 and 2), a papillary muscle 44 (shown in FIGS. 1, 2, and 4), or any combination thereof.
  • In the exemplary embodiment, anchor member 156 is formed with a cork-screw or coil configuration and has a distal end 160 that is pointed and is self-piercing. Accordingly, the anchor member 156 may be fabricated of any material having sufficient rigidity to pierce, and/or at least partially penetrate, through a portion of the cardiac component to which it is intended to be attached. For example, the distal end 156 may be fabricated from, but is not limited to being fabricated from, stainless steel, titanium, various shape memory or superelastic materials, metal alloys, various polymers, and combinations thereof. In an alternative embodiment, the anchor member 156 is not self-tapping, but rather is threadably coupled within a starter hole formed a surgical instrument, such as, but not limited to a piercing catheter or a needle.
  • In one embodiment, anchor member 156 may be formed from a shape memory wire that is annealed or heat-set in a straight configuration and then coiled. In such an embodiment, anchor member 156 may be processed to have different properties by varying the diameter and tension therein along its length. For example, when anchor member 156 is heated to a pre-determined temperature, such as with RF energy, a designated portion of anchor member 156 will become a randomly oriented mass of material having self-locking struts to prevent disentanglement. When the anchor member 156 is heated to a different pre-determined temperature, a full entanglement of occurs such that anchor member 156 is compressed together.
  • In an alternative embodiment, anchor member 156 includes a plurality of tines or arms that are biased outwardly from member 156, and more particularly from tip 160. In such an embodiment, the arms facilitate securing the anchor member 156 in position within the cardiac structure to which it is embedded. Moreover, in other embodiments, anchor member 156 may include expandable arms that expand outwardly from a compressed state. Alternatively, anchor member 156 may include other self-locking struts that facilitate preventing member 156 from backing out of the cardiac structure to which it is threadalby coupled. Furthermore, the cross-sectional shape of anchor member 156 is illustrated as exemplary only. Rather, anchor member 156 and tensioning member 152 may be fabricated with any cross-sectional shape, dimensions, or material that enables fastening mechanism 150 to function as described herein. For example, anchor member 156 may be formed with, but is not limited to being formed with, a self-tapping screw configuration, a mesh configuration, or with a helical configuration.
  • Moreover, in another embodiment, anchor member 156 is formed with a coiled configuration having a helical filament that includes a secondary helical structure that includes, for example, a plurality of loops. In such an embodiment, anchor member 156 may include an inner element fabricated from a shaped memory material and an outer element that is substantially concentrically aligned with respect to the inner element, and is fabricated from a second material, such as a radiopaque material or a heat-activated material. Furthermore, in other embodiments, to facilitate endovascular orientation, the coil may be fabricated with a stacked coil configuration in which no space is defined between adjacent windings of the coil, but rather, the coil assumes a coil configuration when heated to a pre-determined temperature as it is deployed.
  • FIG. 7 is a schematic view of an alternative embodiment of a portion of a tensioning member 200 that may be used to facilitate repair of a cardiac valve 16 (shown in FIGS. 1 and 2). Tensioning member 200 extends between first and second attachment ends 60 and 62 (shown in FIGS. 3 and 4) and in the exemplary embodiment, includes at least two anchoring loops 202 and 204, and an adjustment mechanism 206 extending between loops 202 and 204. In the exemplary embodiment, loops 202 and 204 are each formed integrally with respective attachment ends 60 and 62. In another embodiment, loops 202 and 204 are coupled to ends 60 and 62 using any suitable coupling means.
  • In the exemplary embodiment, adjustment mechanism 206 enables each attachment end 60 and 62 to be coupled to a leaflet 34 (shown in FIGS. 1 and 2) and to any other cardiac structure other than a mitral valve leaflet 34, without tension being induced to either end 60 or 62. Moreover, once ends 60 and 62 are coupled to the leaflet 34 and the cardiac structure, adjustment mechanism 206 enables a pre-determined tension to be induced between the leaflet 34 and the cardiac structure.
  • In the exemplary embodiment, adjustment mechanism 206 functions similarly to a drawstring and includes a locking mechanism 220 that facilitates maintaining a desired tension between the leaflet 34 and the cardiac structure. More specifically, after ends 60 and 62 have each been securely coupled to the leaflet and the cardiac structure, as adjustment loop 222 is pulled away from ends 60 and 62, adjustment mechanism 206 is drawn radially inward between ends 60 and 62, inducing tension between the leaflet 34 and the cardiac structure, and locking mechanism 220 is coupled to adjustment loop 222 to facilitate ensuring that ends 60 and 62 are maintained in their relative position such that the tension induced between ends 60 and 62 is maintained. In an alternative embodiment, adjustment mechanism 206 does not include locking mechanism 222, but rather any suitable method of maintaining the tension between ends 60 and 62 may be utilized, such as, but not limited to, self-locking twist fastener devices or swivel fasteners. Moreover, in a further embodiment, adjustment mechanism 206 does not include locking mechanism 220, but rather the tension induced by the placement of loop 222 is maintained by a knot tied in position adjacent loop 222.
  • In alternative embodiments, other adjustment mechanisms other than mechanism 206 may be used, such as, but not limited to, the installation of a spreader bar mechanism within at least one loop of a daisy chained tension member, the use of a turnbuckle-type mechanism, and/or the use of tensioning member that is shortened as it is twisted, such as would be possible with a tourniquet-type attachment. Moreover, in further alternative embodiments, at least a portion of adjustment mechanism 206 is fabricated from a shaped metal alloy that is formed into a component that when coupled within a fastener assembly either constricts or bows outwardly to induce tension between the ends 60 and 62.
  • FIG. 8 is a flowchart illustrating an exemplary method for the endovascular repair of a cardiac valve. Initially, the mitral valve, or other atrioventricular valve being repaired is accessed percutaneously 300. Depending on the point of vascular access, the approach to the mitral valve may be “antegrade” and require entry into the left atrium by crossing the interatrial septum. Alternatively, approach to the mitral valve can be “retrograde” wherein the left ventricle is entered through the aortic valve. Once access 300 is achieved, the interventional tools and supporting catheter(s) will be positioned 302 endovascularly adjacent the valve being repaired. As will be appreciated by one of ordinary skill in the art, the present invention may be used with open surgical techniques wherein the heart is stopped and the heart valve accessed through the myocardial tissue.
  • The interventional tools used for performing the valve repairs may be specifically designed for use with the present invention, or existing tools may be modified to accommodate the present invention. For example, in one embodiment, a 1° catheter is used to position or guide a plurality of smaller catheters in which the 1° catheter is used to accomplish general positioning of the device relative to the valve being repaired, and the smaller catheters facilitate the more precise positioning necessary to repair the valve in accordance with the present invention. In other embodiments, a guide catheter, a needle bearing catheter, an introducer, or a similar device may be used.
  • Once positioned 302, the leaflet to be repaired is captured 310 and the first attachment end of the fastening mechanism is securely coupled to the leaflet 312. Specifically, as described above, the fastening mechanism may be coupled to the leaflet in a plurality of manners, but in each case, the first attachment end of the mechanism is securely coupled to the valve leaflet in need of repair. The leaflet may be captured 310 using any of a plurality of known methods, including, but not limited to using grasping pins, articulated graspers, vacuum-assisted graspers, or any other suitable method.
  • The second attachment end of the fastening mechanism is then securely coupled 330 to a cardiac structure other than a mitral valve leaflet. The tension induced 332 to the mitral valve leaflet is selected to substantially simulate the same tension, operation, and functionality of a natural chordae member coupled to the leaflet. In at least some embodiments, tension induced to the mitral valve leaflet is adjustable via adjustments of the tensioning member.
  • After repairing the valve leaflet, flow through the valve can be observed by conventional cardiac imaging techniques, such as trans-esophegeal echocardiography (TEE), intracardiac echocardiography (ICE) or other ultrasonic imaging technique, fluoroscopy, angioscopy, catheter based magnetic resonance imaging (MRI), computed tomography (CT) and the like. By observing the flow through the repaired valves, it can be determined whether or not back flow or regurgitation has ceased, or whether the tension induced to the leaflet requires adjustment.
  • Exemplary embodiments of methods and fastener mechanisms for use in repairing atrioventricular valves are described above in detail. Although the methods are herein described and illustrated in association with the above-described atrioventricular valve, it should be understood that the present invention may be used with any atrioventricular valve. More specifically, the fastener mechanisms and methods of repair are not limited to the specific embodiments described herein, but rather, aspects of each fastener mechanism and/or method of repair may be utilized independently and separately from other fastener mechanisms and/or repair methods.
  • While the invention has been described in terms of various specific embodiments, those skilled in the art will recognize that the invention can be practiced with modification within the spirit and scope of the claims.

Claims (18)

1-31. (canceled)
32. A medical kit for use in repairing a mitral valve, said kit comprising:
a guide catheter configured for insertion along the arterial system of the patient to approach the mitral valve without penetrating through a myocardium; and
a fastening mechanism positionable endovascularly within the patient's heart using said guide catheter, said fastening mechanism comprising a first end and an opposite second end, said first end configured to couple to a leaflet of the mitral valve using one of fusing, gluing, stapling, clipping, riveting, anchoring, and suturing, said second end configured to only couple to a cardiac structure other than a valve leaflet to facilitate enhancing operation of the valve during ventricular systole, said fastening mechanism configured to remain securely coupled to the mitral valve leaflet and to and to at least one of a ventricular wall adjacent the atrioventricular valve, a papillary muscle, and a valve annulus, such that the fastening mechanism simulates the function of a native chordae after the guide catheter has been removed from the patient.
33. A medical kit in accordance with claim 32 wherein at least one of said fastening mechanism first and second ends comprises an anchor member comprising at least two arms.
34. A medical kit in accordance with claim 32 wherein at least a portion of said fastening mechanism is braided.
35. A medical kit in accordance with claim 32 wherein said fastening mechanism comprises at least one loop.
36. A medical kit in accordance with claim 32 wherein one of said fastening mechanism first end and said fastening mechanism second end comprises a helical coil.
37. A medical kit in accordance with claim 32 wherein said guide catheter comprises one of a mitral leaflet catheter, a cinching device, and a papillary muscle catheter.
38. A medical kit in accordance with claim 32 wherein said fastening mechanism is fabricated from at least one of a superelastic material, and a shaped memory alloy material.
39. A medical kit in accordance with claim 32 wherein one end of said fastening mechanism comprises a clip configured to couple to an edge of the mitral valve.
40. A medical kit in accordance with claim 32 wherein one end of said fastening mechanism comprises at least one adjustable loop.
41. A medical kit in accordance with claim 32 wherein said fastening mechanism first end is configured to couple to the mitral valve leaflet while the patient's heart remains beating.
42. A medical kit in accordance with claim 41 wherein said fastening mechanism second end is configured to couple to at least one of a ventricular wall adjacent the atrioventricular valve, a papillary muscle, and a valve annulus, while the patient's heart remains beating.
43. A medical kit in accordance with claim 32 wherein said fastening mechanism first end is sized to extend at least partially through an opening formed in the mitral valve leaflet.
44. A fastening mechanism for use in repairing a mitral valve in the heart of a patient by correcting an insufficiency of a valve leaflet of the mitral valve, wherein the valve is connected to at least one natural chordae, said fastening mechanism comprising:
a first end, a second end, and a body extending therebetween, said fastening mechanism configured to be positioned in the patient's heart using at least one of a guide catheter and an interventional tool that positions the fastening mechanism without penetrating a myocardium, said first end configured to couple to the valve leaflet while the heart is non-arrested, said second end configured to couple to a structure other than the valve leaflet, such that said fastening mechanism remains coupled within the heart after the at least one of a guide catheter and an interventional tool has been removed from the patient and simulates the function of a natural chordae.
45. The fastening mechanism in accordance with claim 44 wherein said fastening mechanism is fabricated from at least one of a superelastic material, and a shaped memory alloy material, said fastening mechanism facilitates reducing leakage through the patient's mitral valve.
46. The fastening mechanism in accordance with claim 44 wherein said fastening mechanism first end is configured to be at least one of fused, sutured, riveted, glued, and stapled to the mitral valve leaflet.
47. The fastening mechanism in accordance with claim 44 wherein said fastening mechanism second end is configured to be coupled to a cardiac structure other than the mitral valve leaflet via a fusing, a gluing, a riveting, and a stapling operation.
48. The fastening mechanism in accordance with claim 44 wherein said second end of the fastening mechanism is configured to be threadably coupled to the cardiac structure.
US13/280,112 2005-11-23 2011-10-24 Apparatus for atrioventricular valve repair Abandoned US20120041548A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/280,112 US20120041548A1 (en) 2005-11-23 2011-10-24 Apparatus for atrioventricular valve repair

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/287,011 US8043368B2 (en) 2005-11-23 2005-11-23 Methods and apparatus for atrioventricular valve repair
US13/280,112 US20120041548A1 (en) 2005-11-23 2011-10-24 Apparatus for atrioventricular valve repair

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/287,011 Continuation US8043368B2 (en) 2005-11-23 2005-11-23 Methods and apparatus for atrioventricular valve repair

Publications (1)

Publication Number Publication Date
US20120041548A1 true US20120041548A1 (en) 2012-02-16

Family

ID=38054499

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/287,011 Expired - Fee Related US8043368B2 (en) 2005-11-23 2005-11-23 Methods and apparatus for atrioventricular valve repair
US13/280,112 Abandoned US20120041548A1 (en) 2005-11-23 2011-10-24 Apparatus for atrioventricular valve repair

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US11/287,011 Expired - Fee Related US8043368B2 (en) 2005-11-23 2005-11-23 Methods and apparatus for atrioventricular valve repair

Country Status (4)

Country Link
US (2) US8043368B2 (en)
EP (1) EP1951143A4 (en)
CA (1) CA2631752A1 (en)
WO (1) WO2007062128A2 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9445899B2 (en) 2012-08-22 2016-09-20 Joseph M. Arcidi Method and apparatus for mitral valve annuloplasty
EP3003223A4 (en) * 2013-06-05 2017-01-25 LC Therapeutics, Inc. Synthetic chord for cardiac valve repair applications
WO2017205358A1 (en) * 2016-05-24 2017-11-30 Edwards Lifesciences Corporation Posterior mitral valve leaflet approximation
WO2018204518A1 (en) * 2017-05-05 2018-11-08 Edwards Lifesciences Corporation Papillary muscle binding
US11026791B2 (en) 2018-03-20 2021-06-08 Medtronic Vascular, Inc. Flexible canopy valve repair systems and methods of use
US11058538B2 (en) 2016-03-10 2021-07-13 Charles Somers Living Trust Synthetic chord for cardiac valve repair applications
US11147673B2 (en) 2018-05-22 2021-10-19 Boston Scientific Scimed, Inc. Percutaneous papillary muscle relocation
US11285003B2 (en) 2018-03-20 2022-03-29 Medtronic Vascular, Inc. Prolapse prevention device and methods of use thereof

Families Citing this family (155)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6626899B2 (en) * 1999-06-25 2003-09-30 Nidus Medical, Llc Apparatus and methods for treating tissue
US7976539B2 (en) 2004-03-05 2011-07-12 Hansen Medical, Inc. System and method for denaturing and fixing collagenous tissue
CN101495049B (en) 2005-01-21 2010-12-15 梅约医学教育与研究基金会 Thorascopic heart valve repair method and apparatus
US20060229708A1 (en) * 2005-02-07 2006-10-12 Powell Ferolyn T Methods, systems and devices for cardiac valve repair
WO2011034973A2 (en) * 2005-02-07 2011-03-24 Abbott Vascular Methods, systems and devices for cardiac valve repair
US8608797B2 (en) 2005-03-17 2013-12-17 Valtech Cardio Ltd. Mitral valve treatment techniques
US8951285B2 (en) 2005-07-05 2015-02-10 Mitralign, Inc. Tissue anchor, anchoring system and methods of using the same
US20070118151A1 (en) * 2005-11-21 2007-05-24 The Brigham And Women's Hospital, Inc. Percutaneous cardiac valve repair with adjustable artificial chordae
US7632308B2 (en) * 2005-11-23 2009-12-15 Didier Loulmet Methods, devices, and kits for treating mitral valve prolapse
EP1959866B1 (en) 2005-12-15 2019-03-06 Georgia Tech Research Corporation Papillary muscle position control devices and systems
EP1968492A2 (en) * 2005-12-15 2008-09-17 Georgia Technology Research Corporation Systems and methods to control the dimension of a heart valve
CA2668988A1 (en) * 2005-12-15 2007-09-07 Georgia Tech Research Corporation Systems and methods for enabling heart valve replacement
ITTO20060413A1 (en) * 2006-06-07 2007-12-08 Arrigo Lessana REPLACEMENT DEVICE OF THE TENDONE ROPES OF AN ATRIOVENTRICULAR VALVE
US9974653B2 (en) 2006-12-05 2018-05-22 Valtech Cardio, Ltd. Implantation of repair devices in the heart
US11259924B2 (en) 2006-12-05 2022-03-01 Valtech Cardio Ltd. Implantation of repair devices in the heart
US11660190B2 (en) 2007-03-13 2023-05-30 Edwards Lifesciences Corporation Tissue anchors, systems and methods, and devices
WO2008149355A2 (en) * 2007-06-04 2008-12-11 Mor Research Applications Ltd. Cardiac valve leaflet augmentation
ES2336735B1 (en) * 2007-07-17 2011-01-03 Francisco J. Ilerimplant, S.L. DEVICE TO REPAIR THE INSUFFICIENCY OF THE MITRAL VALVE.
DE102007043830A1 (en) 2007-09-13 2009-04-02 Lozonschi, Lucian, Madison Heart valve stent
US20090088837A1 (en) * 2007-09-28 2009-04-02 The Cleveland Clinic Foundation Prosthetic chordae assembly and method of use
CN101902975B (en) 2007-10-18 2014-06-04 尼奥绰德有限公司 Minimally invasive repair of a valve leaflet in a beating heart
US8382829B1 (en) 2008-03-10 2013-02-26 Mitralign, Inc. Method to reduce mitral regurgitation by cinching the commissure of the mitral valve
DK3967274T3 (en) * 2008-04-23 2022-10-03 Medtronic Inc HEART VALVE DEVICES WITH STENT
EP2296744B1 (en) 2008-06-16 2019-07-31 Valtech Cardio, Ltd. Annuloplasty devices
US20100023118A1 (en) * 2008-07-24 2010-01-28 Edwards Lifesciences Corporation Method and apparatus for repairing or replacing chordae tendinae
US8778016B2 (en) * 2008-08-14 2014-07-15 Edwards Lifesciences Corporation Method and apparatus for repairing or replacing chordae tendinae
US8911494B2 (en) 2009-05-04 2014-12-16 Valtech Cardio, Ltd. Deployment techniques for annuloplasty ring
US9011530B2 (en) 2008-12-22 2015-04-21 Valtech Cardio, Ltd. Partially-adjustable annuloplasty structure
EP2379008B1 (en) 2008-12-22 2021-02-17 Valtech Cardio, Ltd. Adjustable annuloplasty devices
US8715342B2 (en) 2009-05-07 2014-05-06 Valtech Cardio, Ltd. Annuloplasty ring with intra-ring anchoring
US8241351B2 (en) 2008-12-22 2012-08-14 Valtech Cardio, Ltd. Adjustable partial annuloplasty ring and mechanism therefor
US8808368B2 (en) * 2008-12-22 2014-08-19 Valtech Cardio, Ltd. Implantation of repair chords in the heart
US10517719B2 (en) 2008-12-22 2019-12-31 Valtech Cardio, Ltd. Implantation of repair devices in the heart
US8147542B2 (en) 2008-12-22 2012-04-03 Valtech Cardio, Ltd. Adjustable repair chords and spool mechanism therefor
US20110011917A1 (en) * 2008-12-31 2011-01-20 Hansen Medical, Inc. Methods, devices, and kits for treating valve prolapse
US20100210899A1 (en) * 2009-01-21 2010-08-19 Tendyne Medical, Inc. Method for percutaneous lateral access to the left ventricle for treatment of mitral insufficiency by papillary muscle alignment
EP2381852A4 (en) * 2009-01-21 2014-06-11 Tendyne Medical Inc Apical papillary muscle attachment for left ventricular reduction
US8353956B2 (en) 2009-02-17 2013-01-15 Valtech Cardio, Ltd. Actively-engageable movement-restriction mechanism for use with an annuloplasty structure
US8439969B2 (en) * 2009-03-31 2013-05-14 The Cleveland Clinic Foundation Pre-sized prosthetic chordae implantation system
US9968452B2 (en) 2009-05-04 2018-05-15 Valtech Cardio, Ltd. Annuloplasty ring delivery cathethers
US20120179184A1 (en) * 2009-09-15 2012-07-12 Boris Orlov Heart valve remodeling
US10098737B2 (en) 2009-10-29 2018-10-16 Valtech Cardio, Ltd. Tissue anchor for annuloplasty device
US9011520B2 (en) 2009-10-29 2015-04-21 Valtech Cardio, Ltd. Tissue anchor for annuloplasty device
US8940042B2 (en) * 2009-10-29 2015-01-27 Valtech Cardio, Ltd. Apparatus for guide-wire based advancement of a rotation assembly
US9180007B2 (en) 2009-10-29 2015-11-10 Valtech Cardio, Ltd. Apparatus and method for guide-wire based advancement of an adjustable implant
WO2011067770A1 (en) 2009-12-02 2011-06-09 Valtech Cardio, Ltd. Delivery tool for implantation of spool assembly coupled to a helical anchor
US8870950B2 (en) 2009-12-08 2014-10-28 Mitral Tech Ltd. Rotation-based anchoring of an implant
EP2509538B1 (en) 2009-12-08 2017-09-20 Avalon Medical Ltd. Device and system for transcatheter mitral valve replacement
US9107749B2 (en) 2010-02-03 2015-08-18 Edwards Lifesciences Corporation Methods for treating a heart
US8790394B2 (en) 2010-05-24 2014-07-29 Valtech Cardio, Ltd. Adjustable artificial chordeae tendineae with suture loops
US11653910B2 (en) 2010-07-21 2023-05-23 Cardiovalve Ltd. Helical anchor implantation
US9044221B2 (en) 2010-12-29 2015-06-02 Neochord, Inc. Exchangeable system for minimally invasive beating heart repair of heart valve leaflets
EP4119095A1 (en) 2011-03-21 2023-01-18 Cephea Valve Technologies, Inc. Disk-based valve apparatus
US9668860B2 (en) 2011-04-04 2017-06-06 The Medical Research, Infrastructure, and Health Services Fun of Tel Aviv Medical Center Device and method for heart valve repair
EP2713894B1 (en) 2011-06-01 2021-01-20 NeoChord, Inc. System for minimally invasive repair of heart valve leaflets
US10792152B2 (en) 2011-06-23 2020-10-06 Valtech Cardio, Ltd. Closed band for percutaneous annuloplasty
WO2013003228A1 (en) 2011-06-27 2013-01-03 University Of Maryland, Baltimore Transapical mitral valve repair device
CA3040390C (en) 2011-08-11 2022-03-15 Tendyne Holdings, Inc. Improvements for prosthetic valves and related inventions
US8858623B2 (en) 2011-11-04 2014-10-14 Valtech Cardio, Ltd. Implant having multiple rotational assemblies
EP3656434B1 (en) 2011-11-08 2021-10-20 Valtech Cardio, Ltd. Controlled steering functionality for implant-delivery tool
US9827092B2 (en) 2011-12-16 2017-11-28 Tendyne Holdings, Inc. Tethers for prosthetic mitral valve
FR2986149B1 (en) * 2012-01-26 2014-12-26 Ct Hospitalier Universitaire De Clermont Fd DEVICE FOR REPLACING AT LEAST ONE CORDAGE OF THE MITRAL VALVE AND KIT COMPRISING AT LEAST TWO DEVICES
US10076414B2 (en) 2012-02-13 2018-09-18 Mitraspan, Inc. Method and apparatus for repairing a mitral valve
EP2814428A4 (en) 2012-02-13 2016-05-25 Mitraspan Inc Method and apparatus for repairing a mitral valve
US20130289391A1 (en) * 2012-04-27 2013-10-31 Volcano Corporation System and Method Using Forward Looking Imaging for Valve Therapies
WO2014022124A1 (en) 2012-07-28 2014-02-06 Tendyne Holdings, Inc. Improved multi-component designs for heart valve retrieval device, sealing structures and stent assembly
WO2014021905A1 (en) 2012-07-30 2014-02-06 Tendyne Holdings, Inc. Improved delivery systems and methods for transcatheter prosthetic valves
US10022224B2 (en) 2012-08-17 2018-07-17 On-X Life Technologies, Inc. Biological chord repair system and methods
WO2014052818A1 (en) 2012-09-29 2014-04-03 Mitralign, Inc. Plication lock delivery system and method of use thereof
WO2014064694A2 (en) 2012-10-23 2014-05-01 Valtech Cardio, Ltd. Controlled steering functionality for implant-delivery tool
US10376266B2 (en) 2012-10-23 2019-08-13 Valtech Cardio, Ltd. Percutaneous tissue anchor techniques
US9023099B2 (en) 2012-10-31 2015-05-05 Medtronic Vascular Galway Limited Prosthetic mitral valve and delivery method
US9730793B2 (en) 2012-12-06 2017-08-15 Valtech Cardio, Ltd. Techniques for guide-wire based advancement of a tool
EP2948103B1 (en) 2013-01-24 2022-12-07 Cardiovalve Ltd Ventricularly-anchored prosthetic valves
EP2961351B1 (en) 2013-02-26 2018-11-28 Mitralign, Inc. Devices for percutaneous tricuspid valve repair
US10449333B2 (en) 2013-03-14 2019-10-22 Valtech Cardio, Ltd. Guidewire feeder
US9724195B2 (en) 2013-03-15 2017-08-08 Mitralign, Inc. Translation catheters and systems
US9486306B2 (en) 2013-04-02 2016-11-08 Tendyne Holdings, Inc. Inflatable annular sealing device for prosthetic mitral valve
US11224510B2 (en) 2013-04-02 2022-01-18 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US10463489B2 (en) 2013-04-02 2019-11-05 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US10478293B2 (en) 2013-04-04 2019-11-19 Tendyne Holdings, Inc. Retrieval and repositioning system for prosthetic heart valve
US9610159B2 (en) 2013-05-30 2017-04-04 Tendyne Holdings, Inc. Structural members for prosthetic mitral valves
CN105658178B (en) 2013-06-25 2018-05-08 坦迪尼控股股份有限公司 Feature is complied with thrombus management and structure for prosthetic heart valve
US9561103B2 (en) 2013-07-17 2017-02-07 Cephea Valve Technologies, Inc. System and method for cardiac valve repair and replacement
CA2919379C (en) 2013-08-01 2021-03-30 Tendyne Holdings, Inc. Epicardial anchor devices and methods
US10070857B2 (en) 2013-08-31 2018-09-11 Mitralign, Inc. Devices and methods for locating and implanting tissue anchors at mitral valve commissure
WO2015058039A1 (en) 2013-10-17 2015-04-23 Robert Vidlund Apparatus and methods for alignment and deployment of intracardiac devices
US10299793B2 (en) 2013-10-23 2019-05-28 Valtech Cardio, Ltd. Anchor magazine
JP6554094B2 (en) 2013-10-28 2019-07-31 テンダイン ホールディングス,インコーポレイテッド Prosthetic heart valve and system and method for delivering an artificial heart valve
US9526611B2 (en) 2013-10-29 2016-12-27 Tendyne Holdings, Inc. Apparatus and methods for delivery of transcatheter prosthetic valves
US9610162B2 (en) 2013-12-26 2017-04-04 Valtech Cardio, Ltd. Implantation of flexible implant
US9681864B1 (en) 2014-01-03 2017-06-20 Harpoon Medical, Inc. Method and apparatus for transapical procedures on a mitral valve
WO2015120122A2 (en) 2014-02-05 2015-08-13 Robert Vidlund Apparatus and methods for transfemoral delivery of prosthetic mitral valve
US9986993B2 (en) 2014-02-11 2018-06-05 Tendyne Holdings, Inc. Adjustable tether and epicardial pad system for prosthetic heart valve
CA2937566C (en) 2014-03-10 2023-09-05 Tendyne Holdings, Inc. Devices and methods for positioning and monitoring tether load for prosthetic mitral valve
US10195030B2 (en) 2014-10-14 2019-02-05 Valtech Cardio, Ltd. Leaflet-restraining techniques
EP3229736B1 (en) 2014-12-09 2024-01-10 Cephea Valve Technologies, Inc. Replacement cardiac valves and method of manufacture
JP6826035B2 (en) 2015-01-07 2021-02-03 テンダイン ホールディングス,インコーポレイテッド Artificial mitral valve, and devices and methods for its delivery
AU2016215197B2 (en) 2015-02-05 2020-01-02 Tendyne Holdings Inc. Expandable epicardial pads and devices and methods for their delivery
EP3253333B1 (en) 2015-02-05 2024-04-03 Cardiovalve Ltd Prosthetic valve with axially-sliding frames
JP6669780B2 (en) 2015-02-23 2020-03-18 シー・アール・バード・インコーポレーテッドC R Bard Incorporated Access sheath, access system, and related methods
US20160256269A1 (en) 2015-03-05 2016-09-08 Mitralign, Inc. Devices for treating paravalvular leakage and methods use thereof
EP4070763A1 (en) 2015-04-16 2022-10-12 Tendyne Holdings, Inc. Apparatus for retrieval of transcathter prosthetic valves
CN114515173A (en) 2015-04-30 2022-05-20 瓦尔泰克卡迪欧有限公司 Valvuloplasty techniques
EP3294220B1 (en) 2015-05-14 2023-12-06 Cephea Valve Technologies, Inc. Cardiac valve delivery devices and systems
AU2016262564B2 (en) 2015-05-14 2020-11-05 Cephea Valve Technologies, Inc. Replacement mitral valves
US11357499B2 (en) 2015-08-18 2022-06-14 Lsi Solutions, Inc. Apparatus for mitral valve repair and methods thereof
US10327894B2 (en) 2015-09-18 2019-06-25 Tendyne Holdings, Inc. Methods for delivery of prosthetic mitral valves
WO2017059406A1 (en) 2015-10-01 2017-04-06 Neochord, Inc. Ringless web for repair of heart valves
EP3753498B1 (en) 2015-10-02 2023-12-06 Harpoon Medical, Inc. Distal anchor apparatus for mitral valve repair
AU2016362474B2 (en) 2015-12-03 2021-04-22 Tendyne Holdings, Inc. Frame features for prosthetic mitral valves
AU2016380259B2 (en) 2015-12-28 2020-10-22 Tendyne Holdings, Inc. Atrial pocket closures for prosthetic heart valves
US10751182B2 (en) 2015-12-30 2020-08-25 Edwards Lifesciences Corporation System and method for reshaping right heart
WO2017117370A2 (en) 2015-12-30 2017-07-06 Mitralign, Inc. System and method for reducing tricuspid regurgitation
US10531866B2 (en) 2016-02-16 2020-01-14 Cardiovalve Ltd. Techniques for providing a replacement valve and transseptal communication
USD816215S1 (en) 2016-02-23 2018-04-24 C.R. Bard Inc. Access device
US10624743B2 (en) 2016-04-22 2020-04-21 Edwards Lifesciences Corporation Beating-heart mitral valve chordae replacement
US10470877B2 (en) 2016-05-03 2019-11-12 Tendyne Holdings, Inc. Apparatus and methods for anterior valve leaflet management
US10702274B2 (en) 2016-05-26 2020-07-07 Edwards Lifesciences Corporation Method and system for closing left atrial appendage
EP3468480B1 (en) 2016-06-13 2023-01-11 Tendyne Holdings, Inc. Sequential delivery of two-part prosthetic mitral valve
US11331187B2 (en) 2016-06-17 2022-05-17 Cephea Valve Technologies, Inc. Cardiac valve delivery devices and systems
EP3478224B1 (en) 2016-06-30 2022-11-02 Tendyne Holdings, Inc. Prosthetic heart valves and apparatus for delivery of same
GB201611910D0 (en) 2016-07-08 2016-08-24 Valtech Cardio Ltd Adjustable annuloplasty device with alternating peaks and troughs
EP3484411A1 (en) 2016-07-12 2019-05-22 Tendyne Holdings, Inc. Apparatus and methods for trans-septal retrieval of prosthetic heart valves
WO2018029680A1 (en) 2016-08-10 2018-02-15 Mitraltech Ltd. Prosthetic valve with concentric frames
AU2018203053B2 (en) 2017-01-23 2020-03-05 Cephea Valve Technologies, Inc. Replacement mitral valves
CR20190381A (en) 2017-01-23 2019-09-27 Cephea Valve Tech Inc Replacement mitral valves
US10213306B2 (en) 2017-03-31 2019-02-26 Neochord, Inc. Minimally invasive heart valve repair in a beating heart
US10765515B2 (en) 2017-04-06 2020-09-08 University Of Maryland, Baltimore Distal anchor apparatus and methods for mitral valve repair
US11045627B2 (en) 2017-04-18 2021-06-29 Edwards Lifesciences Corporation Catheter system with linear actuation control mechanism
SG11201912367UA (en) 2017-06-19 2020-01-30 Harpoon Medical Inc Method and apparatus for cardiac procedures
WO2019014473A1 (en) 2017-07-13 2019-01-17 Tendyne Holdings, Inc. Prosthetic heart valves and apparatus and methods for delivery of same
WO2019046099A1 (en) 2017-08-28 2019-03-07 Tendyne Holdings, Inc. Prosthetic heart valves with tether coupling features
CN111386083A (en) 2017-10-20 2020-07-07 爱德华兹生命科学公司 Local fusion of native leaflets using activated adhesive
US11065120B2 (en) 2017-10-24 2021-07-20 University Of Maryland, Baltimore Method and apparatus for cardiac procedures
US10835221B2 (en) 2017-11-02 2020-11-17 Valtech Cardio, Ltd. Implant-cinching devices and systems
US11135062B2 (en) 2017-11-20 2021-10-05 Valtech Cardio Ltd. Cinching of dilated heart muscle
CN111655200B (en) 2018-01-24 2023-07-14 爱德华兹生命科学创新(以色列)有限公司 Contraction of annuloplasty structures
WO2019145941A1 (en) 2018-01-26 2019-08-01 Valtech Cardio, Ltd. Techniques for facilitating heart valve tethering and chord replacement
EP3768176B1 (en) 2018-03-23 2024-03-20 NeoChord, Inc. Device for suture attachment for minimally invasive heart valve repair
US11517435B2 (en) 2018-05-04 2022-12-06 Edwards Lifesciences Corporation Ring-based prosthetic cardiac valve
US11253360B2 (en) 2018-05-09 2022-02-22 Neochord, Inc. Low profile tissue anchor for minimally invasive heart valve repair
US11173030B2 (en) 2018-05-09 2021-11-16 Neochord, Inc. Suture length adjustment for minimally invasive heart valve repair
US11224418B2 (en) * 2018-06-15 2022-01-18 Edwards Lifesciences Corporation Papillary muscle approximation pads
CA3106104A1 (en) 2018-07-12 2020-01-16 Valtech Cardio, Ltd. Annuloplasty systems and locking tools therefor
CN113194854A (en) 2018-09-07 2021-07-30 尼奥绰德有限公司 Suture attachment device for minimally invasive heart valve repair
US11413147B2 (en) 2018-10-03 2022-08-16 Edwards Lifesciences Corporation Ventricular remodeling using coil devices
US11413146B2 (en) 2018-10-03 2022-08-16 Edwards Lifesciences Corporation Spring and coil devices for papillary muscle approximation and ventricle remodeling
US11376126B2 (en) 2019-04-16 2022-07-05 Neochord, Inc. Transverse helical cardiac anchor for minimally invasive heart valve repair
EP3962417A4 (en) 2019-05-02 2023-01-18 University of Maryland, Baltimore Valve translocation device and method for the treatment of functional valve regurgitation
CN114786621A (en) 2019-10-29 2022-07-22 爱德华兹生命科学创新(以色列)有限公司 Annuloplasty and tissue anchoring techniques
US11648110B2 (en) 2019-12-05 2023-05-16 Tendyne Holdings, Inc. Braided anchor for mitral valve
US11648114B2 (en) 2019-12-20 2023-05-16 Tendyne Holdings, Inc. Distally loaded sheath and loading funnel
US11678980B2 (en) 2020-08-19 2023-06-20 Tendyne Holdings, Inc. Fully-transseptal apical pad with pulley for tensioning
CN114569291B (en) 2022-05-07 2022-08-23 杭州德晋医疗科技有限公司 Atrioventricular valve clamping device and atrioventricular valve clamping system

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105519A1 (en) * 1997-09-04 2003-06-05 Roland Fasol Artificial chordae replacement
US6629534B1 (en) * 1999-04-09 2003-10-07 Evalve, Inc. Methods and apparatus for cardiac valve repair

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6332893B1 (en) 1997-12-17 2001-12-25 Myocor, Inc. Valve to myocardium tension members device and method
US6926730B1 (en) 2000-10-10 2005-08-09 Medtronic, Inc. Minimally invasive valve repair procedure and apparatus
US20050070999A1 (en) * 2000-02-02 2005-03-31 Spence Paul A. Heart valve repair apparatus and methods
US20050125011A1 (en) * 2001-04-24 2005-06-09 Spence Paul A. Tissue fastening systems and methods utilizing magnetic guidance
WO2002102237A2 (en) * 2001-06-15 2002-12-27 The Cleveland Clinic Foundation Tissue engineered mitral valve chrodae and methods of making and using same
US7144363B2 (en) * 2001-10-16 2006-12-05 Extensia Medical, Inc. Systems for heart treatment
GB0125925D0 (en) * 2001-10-29 2001-12-19 Univ Glasgow Mitral valve prosthesis
US20030120341A1 (en) * 2001-12-21 2003-06-26 Hani Shennib Devices and methods of repairing cardiac valves
US8287555B2 (en) * 2003-02-06 2012-10-16 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US20050240202A1 (en) * 2004-04-21 2005-10-27 Hani Shennib Devices and methods of repairing cardiac valves
WO2006041877A2 (en) 2004-10-05 2006-04-20 Ample Medical, Inc. Atrioventricular valve annulus repair systems and methods including retro-chordal anchors
US20070118151A1 (en) 2005-11-21 2007-05-24 The Brigham And Women's Hospital, Inc. Percutaneous cardiac valve repair with adjustable artificial chordae
US7632308B2 (en) * 2005-11-23 2009-12-15 Didier Loulmet Methods, devices, and kits for treating mitral valve prolapse
US7635386B1 (en) * 2006-03-07 2009-12-22 University Of Maryland, Baltimore Methods and devices for performing cardiac valve repair
US20080228272A1 (en) * 2006-12-04 2008-09-18 Micardia Corporation Dynamically adjustable suture and chordae tendinae
US20100023118A1 (en) * 2008-07-24 2010-01-28 Edwards Lifesciences Corporation Method and apparatus for repairing or replacing chordae tendinae

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105519A1 (en) * 1997-09-04 2003-06-05 Roland Fasol Artificial chordae replacement
US6629534B1 (en) * 1999-04-09 2003-10-07 Evalve, Inc. Methods and apparatus for cardiac valve repair

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9445899B2 (en) 2012-08-22 2016-09-20 Joseph M. Arcidi Method and apparatus for mitral valve annuloplasty
EP3003223A4 (en) * 2013-06-05 2017-01-25 LC Therapeutics, Inc. Synthetic chord for cardiac valve repair applications
US11058538B2 (en) 2016-03-10 2021-07-13 Charles Somers Living Trust Synthetic chord for cardiac valve repair applications
WO2017205358A1 (en) * 2016-05-24 2017-11-30 Edwards Lifesciences Corporation Posterior mitral valve leaflet approximation
WO2018204518A1 (en) * 2017-05-05 2018-11-08 Edwards Lifesciences Corporation Papillary muscle binding
US11026791B2 (en) 2018-03-20 2021-06-08 Medtronic Vascular, Inc. Flexible canopy valve repair systems and methods of use
US11285003B2 (en) 2018-03-20 2022-03-29 Medtronic Vascular, Inc. Prolapse prevention device and methods of use thereof
US11701228B2 (en) 2018-03-20 2023-07-18 Medtronic Vascular, Inc. Flexible canopy valve repair systems and methods of use
US11931261B2 (en) 2018-03-20 2024-03-19 Medtronic Vascular, Inc. Prolapse prevention device and methods of use thereof
US11147673B2 (en) 2018-05-22 2021-10-19 Boston Scientific Scimed, Inc. Percutaneous papillary muscle relocation
US11678988B2 (en) 2018-05-22 2023-06-20 Boston Scientific Scimed, Inc. Percutaneous papillary muscle relocation

Also Published As

Publication number Publication date
US8043368B2 (en) 2011-10-25
EP1951143A2 (en) 2008-08-06
CA2631752A1 (en) 2007-05-31
WO2007062128A3 (en) 2007-10-18
US20070118154A1 (en) 2007-05-24
EP1951143A4 (en) 2011-01-12
WO2007062128A2 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
US8043368B2 (en) Methods and apparatus for atrioventricular valve repair
US20230277169A1 (en) Systems and methods for anchoring an implant
JP7136806B2 (en) Method and device for transvascular implantation of newly formed chordae tendineae
US8187299B2 (en) Methods and apparatus for cardiac valve repair
AU2003282982B2 (en) Method and apparatus for performing catheter-based annuloplasty using local plications
JP4253582B2 (en) Method and device for capturing and securing leaflets in valve therapy
US10327743B2 (en) Device and methods for endoscopic annuloplasty
AU2006241065B2 (en) Device and methods for endoscopic annuloplasty
CN117642137A (en) Devices and methods for solving valve leaflet problems
WO2011034973A2 (en) Methods, systems and devices for cardiac valve repair
JP2009519783A (en) Papillary muscle position control device, system and method

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION